Patricia Stephenson
Dartmouth Institute for Health Policy and Clinical Practice(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, HER2/EGFR in Cancer Research, Lung Cancer Research Studies, Healthcare Policy and Management
Most-Cited Works
- → Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer(2014)1,981 cited
- → Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study(2012)1,275 cited
- → Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure(2009)366 cited
- → Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After First-Line Chemotherapy: Eastern Cooperative Oncology Group Trial E2196(2004)265 cited
- → Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC).(2014)256 cited
- → Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598(2004)225 cited
- → Clinical activity of crizotinib in advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement.(2012)129 cited
- → Commentary: the public health consequences of restricted induced abortion--lessons from Romania.(1992)105 cited
- → Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK.(1997)101 cited
- → Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590(2005)71 cited